So-called “cancer vaccine” isn’t a vaccine at all; it’s actually immunotherapy that boosts the body’s own immune function

So-called “cancer vaccine” isn’t a vaccine at all; it’s actually immunotherapy that boosts the body’s own immune function

Sunday, February 18, 2018 by: Tracey Watson

Tags: advanced medicine, cancer, cancer breakthroughs, cancer treatment, cancer vaccines, goodcancer, goodmedicine, goodscience, healing, immune system, immunity, immunotherapy, medical technology, vaccines

5,610
Views

(Natural News) There is no doubt that a cancer diagnosis is absolutely devastating. Sadly, most of us have been affected by this disease, either directly or through having to watch a friend or family member suffer with it. It is therefore understandable that the idea of a cancer vaccine would be wholeheartedly embraced by most people. Imagine if by just having a shot you could guarantee that you would never get cancer in your lifetime. Sounds good, right?
Well, the vaccine propaganda machine has latched onto a promising new cancer treatment and is calling it a cancer vaccine – but it isn’t a vaccine at all. It is a type of immunotherapy which triggers the body’s own immune system to fight the disease.
The distinction matters, because while this type of immunotherapy treatment is cost-effective and unlikely to cause any side effects, vaccines contain dodgy ingredients like thimerosal (mercury) and cells derived from aborted baby fetuses, in addition to causing a host of serious adverse health effects.
The World Health Organization defines a vaccine as follows:
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body’s immune system to recognize the agent as foreign, destroy it, and “remember” it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. [Emphasis added]
So, in very simplified terms, a vaccine involves injecting a small amount of a disease into the body so that the body can destroy it and then remember it. If a person is exposed to that disease at a later stage, the body’s own immune system will “remember” how to fight it off and the person won’t get sick — at least, in theory.
That would be great if children weren’t inundated with dozens of vaccines, some in combination, and all within a relatively short time period, and if they didn’t contain dangerous preservatives and adjuvants. (Related: Fake news is what you get when the mainstream media tells you vaccines are completely safe.)
Immunotherapy, on the other hand, does not involve introducing the body to a small amount of the disease so it can “learn” to fight it off; it simply stimulates the body’s own immune processes to destroy disease.
A team of researchers from Stanford University claims to have created an immunotherapy treatment which can be injected directly into a tumor, resulting in the destruction of that tumor as well as any others in the body, all by stimulating a full body defensive response by the immune system. (Discover why boosting your own immune system is more effective than dangerous chemotherapy treatments at Chemotherapy.news.)
The Daily Mail explained how the treatment works:
The method works to reactivate the cancer-specific T cells by injecting microgram (a millionth of a gram) amounts of two agents directly into the tumor site.
The first, a short stretch of DNA, works with nearby immune cells to heighten the expression of an activating receptor on the surface of the T cells.
The second, an antibody that binds to the receptor, activates the T cells to attack the cancer cells.
By injecting it direct [sic] into the tumor, it is specifically training T cells which already recognize cancer because they are already inside it.
The research team is now ready to move on to human trials and is looking for 15 patients with low-grade lymphoma to participate in the next phase of the study. They feel positive that in future this type of treatment could successfully treat many different types of cancer.
“I don’t think there’s a limit to the type of tumor we could potentially treat, as long as it has been infiltrated by the immune system,” Professor Ronald Levy, the study’s lead author, told the Mail.
Sources include:
DailyMail.co.uk
WHO.int